Researchers at MIT and Brigham and Women’s Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks. Unlike N95 masks, the new masks were designed to be easily sterilized and used many times.
As the number of new Covid-19 cases in the United States continues to rise, there is still an urgent need for N95 masks for health care workers and others. The new mask is made of durable silicone rubber and can be manufactured using injection molding, which is widely used in factories around the world. The mask also includes an N95 filter, but it requires much less N95 material than a traditional N95 mask.
“One of the key things we recognized early on was that in order to help meet the demand, we needed to really restrict ourselves to methods that could scale,” says Giovanni Traverso, an MIT assistant professor of mechanical engineering and a gastroenterologist at Brigham and Women’s Hospital. “We also wanted to maximize the reusability of the system, and we wanted systems that could be sterilized in many different ways.”
The team is now working on a second version of the mask, based on feedback from health care workers, and is working to establish a company to support scaled-up production and seek approval from the FDA and the National Institute for Occupational Safety and Health (NIOSH).
Traverso is the senior author of a paper describing the new masks, which appears today in the British Medical Journal Open. The lead authors of the study are James Byrne, a radiation oncologist at Brigham and Women’s Hospital and research affiliate at MIT’s Koch Institute for Integrative Cancer Research; Adam Wentworth, a research engineer at Brigham and Women’s Hospital and a research affiliate at the Koch Institute; Peter Chai, an emergency medicine physician at Brigham and Women’s Hospital; and Hen-Wei Huang, a research fellow at Brigham and Women’s Hospital and a postdoc at the Koch Institute.
Image Credit: MIT Researchers
Thanks to Heinz V. Hoenen. Follow him on twitter: @HeinzVHoenen
News This Week
MIT algorithm discovers antibiotic that can fight drug-resistant diseases
A deep learning algorithm developed at MIT has discovered new antibiotics that can treat drug-resistant diseases by killing 35 powerful bacteria. The pathogens that the halicin antibiotic has targetted include Acinetobacter baumannii, which was nicknamed [...]
Article: ‘Digital Rights in the Age of Super Intelligence’ by Eva Kaili
In our transforming world, digital technology has the critical mass to push our frontiers and release unlimited potential. As the wave of digital transformation soars high, improving our lives, industries and economies, we must not [...]
Scientists Discover a Way to Control the Immune System’s “Natural Killer” Cells With “Invisible” Stem Cells
UC San Francisco scientists have discovered a new way to control the immune system’s “natural killer” (NK) cells, a finding with implications for novel cell therapies and tissue implants that can evade immune rejection. The [...]
Simulations Reveal Nature’s Design For Error Correction During DNA Replication
A team led by scientists at Georgia State University simulates the precise transition between the processes of DNA synthesis and proofreading DNA replication is one of the most important processes in biology, responsible for ensuring [...]
‘Long Covid’ is anything but a mild illness
With the excitement of the Covid vaccine’s arrival, it may be easy to forget and ignore those of us with “long Covid”, who are struggling to reclaim our previous, pre-viral lives and continue to live [...]
Could COVID-19 have wiped out the Neandertals?
Everybody loves Neandertals, those big-brained brutes we supposedly outcompeted and ultimately replaced using our sharp tongues and quick, delicate minds. But did we really, though? Is it mathematically possible that we could yet be them, [...]
Inside Oxford’s coronavirus vaccine development
From a small discovery to producing at scale, photojournalist David Levene documents the groundbreaking work of the scientists of Oxford University during the development of a vaccine which is now poised for approval by medicines regulators. [...]
From molecule to medicine via machine learning
t typically takes many years of experiments to develop a new medicine. Although vaccines to protect against disease from the novel coronavirus are starting to reach clinics around the world, patients and doctors will still [...]
First Optical Tweezers Capable of Trapping Nanoparticles
Optical tweezers are a rapidly growing technology, and have opened up a wide variety of research applications in recent years. The devices operate by trapping particles at the focal points of tightly focused laser beams, [...]
Brain Implants Enable Man to Simultaneously Control Two Prosthetic Limbs with ‘Thoughts’
In what is believed to be a medical first, researchers from Johns Hopkins Medicine (JHM) and the Johns Hopkins University Applied Physics Laboratory (APL) have enabled a quadriplegic man to control a pair of prosthetic [...]
How to use antibodies to control chemical reactions
Antibodies are remarkable biomarkers: they are the cues that provide us with indications about many diseases and how our immune system counter them. Now a group of scientists from the University of Rome, Tor Vergata [...]
How COVID-19 Reaches the Brain
Using post-mortem tissue samples, a team of researchers from Charité – Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune system [...]
Medicine-carriers made from human cells can cure lung infections
Scientists used human white blood cell membranes to carry two drugs, an antibiotic and an anti-inflammatory, directly to infected lungs in mice. The nano-sized drug delivery method developed at Washington State University successfully treated both [...]
Quantum nanodiamonds may help detect disease earlier
The quantum sensing abilities of nanodiamonds can be used to improve the sensitivity of paper-based diagnostic tests, potentially allowing for earlier detection of diseases such as HIV, according to a study led by UCL researchers [...]
‘Nanobodies’ could hold clues to new COVID-19 therapies
WEHI researchers are studying 'nanobodies' – tiny immune proteins made by alpacas—in a bid to understand whether they might be effective in blocking SARS-CoV-2, the virus that causes COVID-19. Alpacas produce unique antibodies—called nanobodies—that can [...]
Oxford University breakthrough on global COVID-19 vaccine
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a [...]
